Advertisement

Screening for Substance Use and Associated Medical Conditions

  • Jesse W. Schram
  • Patricia C. F. SchramEmail author
  • John R. Knight
Chapter

Abstract

Early onset of substance use leads to a higher risk of developing psychosocial problems and a lifelong substance use disorder, which makes screening, prevention, and early intervention instrumental in moderating potential harm. Substance use can be viewed along a continuum from experimentation to problematic substance use and to mild, moderate, and severe substance use disorders. Nonmedical use of prescription medications also operates under a similar continuum and is particularly relevant to the adolescent age group since prescription medications may be more available to young people in some settings than are other substances. This chapter discusses key revisions from the DSM-IV to the DSM-5 and briefly explains how shifts in the diagnostic process impact the implementation of various screening tools. Evidence-based screening instruments are presented and described in detail. Additional health screening recommendations are outlined due to the high-risk behaviors associated with substance use.

Keywords

Adolescent Substance use Substance use screening DSM-5 CRAFFT S2BI 

References

  1. 1.
    Poudel A, Gautam S. Age of onset of substance use and psychosocial problems among individuals with substance use disorders. BMC Psychiatry. 2017;17(1):10.CrossRefGoogle Scholar
  2. 2.
    Bava S, Thayer R, Jacobus J, Ward M, Jernigan TL, Tapert SF. Longitudinal characterization of white matter maturation during adolescence. Brain Res. 2010;1327:38–46.CrossRefGoogle Scholar
  3. 3.
    American Psychiatric Association. DSM-IV-TR. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC. Substance-related disorders. 2000;191–297.Google Scholar
  4. 4.
    American Psychiatric Association. DSM-5. Diagnostic and statistical manual of mental disorders 5th ed. Substance-related and addictive disorders. 2013;481–589.Google Scholar
  5. 5.
    Rahim M, Patton R. The association between shame and substance use in young people: a systematic review. PeerJ. 2015;3:e737.CrossRefGoogle Scholar
  6. 6.
    Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–7.CrossRefGoogle Scholar
  7. 7.
    Ramirez J, Miranda R. Alcohol craving in adolescents: bridging the laboratory and natural environment. Psychopharmacology. 2014;231(8):1841–51.CrossRefGoogle Scholar
  8. 8.
    Agrawal A, Heath AC, Lynskey MT. DSM-IV to DSM-5: the impact of proposed revisions on diagnosis of alcohol use disorders. Addiction. 2011;106(11):1935–43.CrossRefGoogle Scholar
  9. 9.
    Hasin DS, Fenton MC, Beseler C, Park JY, Wall MM. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend. 2012;122(1–2):28–37.CrossRefGoogle Scholar
  10. 10.
    Slade EP, Stuart EA, Salkever DS, Karakus M, Green KM, Ialongo N. Impacts of age of onset of substance use disorders on risk of adult incarceration among disadvantaged urban youth: a propensity score matching approach. Drug Alcohol Depend. 2008;95(1–2):1–13.CrossRefGoogle Scholar
  11. 11.
    Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161210.CrossRefGoogle Scholar
  12. 12.
    Pilowsky DJ, Wu L-T. Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav. 2013;38(5):2146–53.CrossRefGoogle Scholar
  13. 13.
    Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup. 2017 recommendations for preventive pediatric health care. Pediatrics American Academy of Pediatrics. 2017;139(4):e20170254.Google Scholar
  14. 14.
    Wilson CR, Sherritt L, Gates E, Knight JR. Are clinical impressions of adolescent substance use accurate? Pediatrics. 2004;114(5):e536–40.CrossRefGoogle Scholar
  15. 15.
    Kelly TM, Donovan JE, Chung T, Bukstein OG, Cornelius JR. Brief screens for detecting alcohol use disorder among 18-20 year old young adults in emergency departments: comparing AUDIT-C, CRAFFT, RAPS4-QF, FAST, RUFT-cut, and DSM-IV 2-item scale. Addict Behav. 2009;34(8):668–74.CrossRefGoogle Scholar
  16. 16.
    Knight JR, Sherritt L, Harris SK, Gates EC, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res. 2003;27(1):67–73.CrossRefGoogle Scholar
  17. 17.
    Cook RL, Chung T, Kelly TM, Clark DB. Alcohol screening in young persons attending a sexually transmitted disease clinic. Comparison of AUDIT, CRAFFT, and CAGE instruments. J Gen Intern Med. 2005;20(1):1–6.CrossRefGoogle Scholar
  18. 18.
    Dhalla S, Zumbo BD, Poole G. A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57–64.CrossRefGoogle Scholar
  19. 19.
    D’Amico EJ, Parast L, Meredith LS, Ewing BA, Shadel WG, Stein BD. Screening in primary care: what is the best way to identify at-risk youth for substance use? Pediatrics. 2016;138(6):e20161717.CrossRefGoogle Scholar
  20. 20.
    Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O’Grady KE, Kirk AS, et al. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination. Subst Abus. 2014;35(4):376–80.CrossRefGoogle Scholar
  21. 21.
    Skogen JC, Bøe T, Knudsen AK, Hysing M. Psychometric properties and concurrent validity of the CRAFFT among Norwegian adolescents. Ung@hordaland, a population-based study. Addict Behav. 2013;38(10):2500–5.CrossRefGoogle Scholar
  22. 22.
    Kandemir H, Aydemir Ö, Ekinci S, Selek S, Kandemir SB, Bayazit H. Validity and reliability of the Turkish version of CRAFFT substance abuse screening test among adolescents. Neuropsychiatr Dis Treat. 2015;11:1505–9.CrossRefGoogle Scholar
  23. 23.
    Wartberg L, Kriston L, Diestelkamp S, Arnaud N, Thomasius R. Psychometric properties of the German version of the CRAFFT. Addict Behav. 2016;59:42–7.CrossRefGoogle Scholar
  24. 24.
    Harris SK, Johnson JK, Sherritt L, Copelas S, Rappo MA, Wilson CR. Putting adolescents at risk: riding with drinking drivers who are adults in the home. J Stud Alcohol Drugs. 2017;78(1):146–51.CrossRefGoogle Scholar
  25. 25.
    U.S. Department of Transportation, National Highway Traffic Safety Administration (NHTSA). Traffic safety facts 2014. https://crashstats.nhtsa.dot.gov/Api/Public/Publication/812261. Accessed 23 July 2018.
  26. 26.
    Levy S, Weiss R, Sherritt L, Ziemnik R, Spalding A, Van Hook S, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822–8.CrossRefGoogle Scholar
  27. 27.
    Subramaniam GA, Volkow ND. Substance misuse among adolescents. JAMA Pediatr. 2014;168(9):798.CrossRefGoogle Scholar
  28. 28.
    Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, et al. Adolescents’ preference for substance abuse screening in primary care practice. Subst Abus. 2007;28(4):107–17.CrossRefGoogle Scholar
  29. 29.
    Harris SK, Csémy L, Sherritt L, Starostova O, Van Hook S, Johnson J, et al. Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial. Pediatrics. 2012;129(6):1072–82.CrossRefGoogle Scholar
  30. 30.
    Richardson LP, Rockhill C, Russo JE, Grossman DC, Richards J, McCarty C, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics. 2010;125(5):e1097–103.CrossRefGoogle Scholar
  31. 31.
    Services USD of H and H. Mandatory guidelines for federal workplace drug testing. Subst Abus Ment Heal Serv Adm. 2004;69(71):1.Google Scholar
  32. 32.
    Levy S, Siqueira LM. Testing for drugs of abuse in children and adolescents. Pediatrics. 2014;133(6):e1798–807.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Jesse W. Schram
    • 1
  • Patricia C. F. Schram
    • 2
    • 3
    Email author
  • John R. Knight
    • 3
    • 4
  1. 1.Department of Social Work, Adolescent Substance Use and Addiction ProgramBoston Children’s HospitalBostonUSA
  2. 2.Department of MedicineBoston Children’s HospitalBostonUSA
  3. 3.Department of PediatricsHarvard Medical SchoolBostonUSA
  4. 4.Department of Medicine and PsychiatryBoston Children’s HospitalBostonUSA

Personalised recommendations